Concepedia

Author

Chinghai Kao

Indiana University – Purdue University Indianapolis

Also Known As

C H Kao, C Kao, C. Kao, CHINGHAI KAO, Caleb S. Kao, Chen-Chien Kao, Chinghai H. Kao, Chinghai Kao, Chinghai Kao1, Kao, Chinghai

198

Publications

4.4K

Citations

35

H-Index

86

Concepts

All Affiliations

Indiana University – Purdue University IndianapolisIndiana University School of MedicineUniversity of VirginiaUniversity of Wisconsin–MadisonEmory University
CK

About

Chinghai Kao is an author at Indiana University – Purdue University Indianapolis specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

24

1.3K

2

Engineering

4

4

192

3

Health Sciences

4

4

400

4

Natural Sciences

3

3

129

5

Public Health

1

1

12

Chinghai Kao

×

69

Publications

4.2K

Citations

35

H-Index

YearCitations

Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

Tony T. Wu, Robert A. Sikes, Quanjun Cui,

International Journal of Cancer

1998

290

Androgen-repressed phenotype in human prostate cancer

Hai Yen E. Zhau, Shi‐Ming Chang, Bao-Qi Chen,

Proceedings of the National Academy of Sciences

1996

229

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status

Heng Hong, Chinghai Kao, Meei‐Huey Jeng,

Cancer

2004

205

Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures

Xudong Li, Quanjun Cui, Chinghai Kao,

Bone

2003

170

An Ultrasonically Powered Implantable Micro-Oxygen Generator (IMOG)

T. Maleki, Ning Cao, Seung Hyun Song,

IEEE Transactions on Biomedical Engineering

2011

152

Overcoming cellular senescence in human cancer pathogenesis

Thomas R. Yeager, Sandy DeVries, David F. Jarrard,

Genes & Development

1998

151

A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.

Shigeji Matsubara, Yoshitaka Wada, Thomas A. Gardner,

PubMed

2001

149

The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis

Catherine E. Steding, Sung-tse Wu, Yanping Zhang,

Immunology

2011

132

Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate Cancer

Hiroyuki Kubo, Thomas A. Gardner, Yoshitaka Wada,

Human Gene Therapy

2003

127

Molecular Therapy with Recombinant p53 Adenovirus in an Androgen-Independent, Metastatic Human Prostate Cancer Model

Song-Chu Ko, Akinobu Gotoh, George N. Thalmann,

Human Gene Therapy

1996

125

Page 1